Insights & Analysis

Industry insights that are curated and delivered to inform your dealmaking strategies. We select the most relevant information, providing a consistent, convenient source for exclusive intelligence and analysis.

All News Activism M&A Podcasts Private Cos. Private Equity Restructuring Scoops & Exclusives SPACs

Page 54

M&A

Drinks With The Deal: Latham's Luke Bergstrom

By David Marcus
|
Published: November 6th, 2020
The San Francisco-based partner discusses managing the firm's global M&A and technology groups and how he uses his love of cocktails as a way to build client relationships.
Activism

Activist Investing Today: Zacchei Eyes Post-Election Activism, and more

By Ronald Orol
|
Published: October 22nd, 2020
Sloane’s Dan Zacchei explains why activism can be compared to pro sports in the context of the pandemic, how PE and activists are teaming up and what to expect in the industry post-election on the latest episode of Activist Investing Today.
M&A

Drinks With The Deal: Cravath's Damien Zoubek

By David Marcus
|
Published: October 15th, 2020
The M&A partner discusses changing attitudes toward ESG, the effects of the pandemic on corporate practice and his love of wine in the latest episode of the podcast.
Activism

Activist Investing Today: Coffee Weighs DOL Rules Impact on ESG

By Ronald Orol
|
Published: October 7th, 2020
Columbia Law School professor John Coffee talks about why he thinks a new Labor Department proposal represents a rifle shot against environmental, social and governance investing, during the latest episode of the Activist Investing Today podcast.
Activism

Elliott Puts More Stress on ESG

By Nikitha Sattiraju
|
Published: September 28th, 2020
While Elliott will never be an ESG fund, it's paying more attention to ESG considerations in all of its investments, according to Christine O'Brien, head of investment stewardship at the firm.
Podcasts

Behind the Buyouts: VSS's Stevenson Takes the Long View

By Steve Gelsi
|
Published: September 23rd, 2020
VSS' Jeffrey Stevenson says the firm's focus on subscription revenue in the media and business information services sectors led it to sharpen its focus on SaaS and healthcare IT deals in recent years.
 Company
Solutions
Contact The Deal
Tel:
1-888-667-3325
International:
+1-212-224-3069
Email:
[email protected]
© 2024 The Deal.

Part of the Delinian Group. Terms of Use, Commercial Terms & Conditions, Privacy Policy, Accessibility, Modern Slavery Act